Dashenlin Pharm Grp Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.096x

Dashenlin Pharm Grp Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Dashenlin Pharm Grp Co Ltd (603233) has a cash flow conversion efficiency ratio of 0.096x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥818.72 Million ≈ $119.80 Million USD) by net assets (CN¥8.49 Billion ≈ $1.24 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Dashenlin Pharm Grp Co Ltd (2012–2025)

Cash flow conversion efficiency of Dashenlin Pharm Grp Co Ltd from 2012 to 2025. This chart illustrates how Dashenlin Pharm Grp Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 603233 stock price and chart for real-time trading data and today's change.

Dashenlin Pharm Grp Co Ltd Cash Flow Conversion Ratio Explained

Dashenlin Pharm Grp Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Dashenlin Pharm Grp Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dashenlin Pharm Grp Co Ltd ranked by their cash flow conversion efficiency. Also see market value of Dashenlin Pharm Grp Co Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Sacyr SA MC:SCYR	0.038x
Brickworks Ltd AU:BKW	0.018x
TUI AG XETRA:TUI1	-0.618x
Kimberly-Clark de México S. A. B. de C. V MX:KIMBERA	0.486x
First Capital Securities Co Ltd Class A SHE:002797	0.035x
RXO Inc. NYSE:RXO	-7.323x
China Coal Xinji Energy Co Ltd SHG:601918	0.023x
Peyto Exploration&Development Corp TO:PEY	0.074x

Annual Cash Flow Conversion Efficiency for Dashenlin Pharm Grp Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Dashenlin Pharm Grp Co Ltd from 2012 to 2025. Review 603233 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥8.66 Billion ≈ $1.27 Billion	CN¥5.35 Billion ≈ $782.90 Million	0.618x	+61.83%
2024-12-31	CN¥8.14 Billion ≈ $1.19 Billion	CN¥3.11 Billion ≈ $454.55 Million	0.382x	-4.60%
2023-12-31	CN¥7.93 Billion ≈ $1.16 Billion	CN¥3.17 Billion ≈ $464.43 Million	0.400x	-26.90%
2022-12-31	CN¥6.86 Billion ≈ $1.00 Billion	CN¥3.76 Billion ≈ $549.70 Million	0.547x	+108.91%
2021-12-31	CN¥5.94 Billion ≈ $868.61 Million	CN¥1.55 Billion ≈ $227.54 Million	0.262x	-25.28%
2020-12-31	CN¥5.57 Billion ≈ $815.49 Million	CN¥1.95 Billion ≈ $285.92 Million	0.351x	-11.07%
2019-12-31	CN¥4.33 Billion ≈ $633.86 Million	CN¥1.71 Billion ≈ $249.90 Million	0.394x	+39.29%
2018-12-31	CN¥3.09 Billion ≈ $451.68 Million	CN¥873.64 Million ≈ $127.84 Million	0.283x	+23.87%
2017-12-31	CN¥2.80 Billion ≈ $410.12 Million	CN¥640.39 Million ≈ $93.71 Million	0.228x	-38.12%
2016-12-31	CN¥1.34 Billion ≈ $196.39 Million	CN¥495.60 Million ≈ $72.52 Million	0.369x	-19.52%
2015-12-31	CN¥1.02 Billion ≈ $149.43 Million	CN¥468.59 Million ≈ $68.57 Million	0.459x	-41.20%
2014-12-31	CN¥574.85 Million ≈ $84.12 Million	CN¥448.58 Million ≈ $65.64 Million	0.780x	+59.72%
2013-12-31	CN¥589.93 Million ≈ $86.32 Million	CN¥288.22 Million ≈ $42.18 Million	0.489x	-35.64%
2012-12-31	CN¥381.11 Million ≈ $55.77 Million	CN¥289.31 Million ≈ $42.34 Million	0.759x	--

About Dashenlin Pharm Grp Co Ltd

SHG:603233 China Pharmaceutical Retailers

Market Cap

$3.58 Billion

CN¥24.47 Billion CNY

Market Cap Rank

#4274 Global

#618 in China

Share Price

CN¥21.49

Change (1 day)

+3.72%

52-Week Range

CN¥14.80 - CN¥21.49

All Time High

CN¥57.53